Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $5.04 billion as of November 20, 2026. It is the 3,406th most valuable company in the world and the 1,109th biggest in the United States. Its market cap has decreased by 25.23% in one year.
Market Cap
5.04B
Enterprise Value
4.74B
1-Year Change
-25.23%
Global Rank
Country Rank
#1,109 United States
Category
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $5.04B, a decrease of -15.33%. That is a compound annual growth rate of -11.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 5.04B | -33.77% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 (IPO) | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 5.85B |
| Ligand Pharmaceuticals | 5.74B |
| Belite Bio | 5.17B |
| Veradermics | 5.04B |
| Erasca | 4.78B |
| Dianthus Therapeutics | 4.76B |
| PTC Therapeutics | 4.71B |
| Cogent Biosciences | 4.65B |